Gujarat Kidney & Super Speciality IPO
Gujarat Kidney & Super Speciality IPO Details
-
Open Date
22 Dec 2025
-
Close Date
24 Dec 2025
-
Listing Date
30 Dec 2025
- IPO Price Range
₹ 108 to ₹114
- IPO Size
₹ 250.80 Cr
- Listing Exchange
BSE NSE
Gujarat Kidney & Super Speciality IPO Timeline
Gujarat Kidney & Super Speciality IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 22-Dec-2025 | 0.34 | 1.97 | 4.75 | 1.48 |
| 23-Dec-2025 | 0.34 | 2.95 | 10.46 | 2.68 |
| 24-Dec-2025 | 1.06 | 5.72 | 18.91 | 5.19 |
Last Updated: 24 December 2025 5:24 PM by 5paisa
Gujarat Kidney and Super Speciality Limited (GKASSL) delivers multispeciality healthcare across Gujarat, India, operating seven hospitals and four pharmacies with 490 beds (455 approved, 340 operational). Its facilities include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre and Store (Anand). Services span secondary care, general and surgical treatments, and tertiary care, including super-speciality procedures in medicine, surgery, orthopaedics, cardiology, diabetology, obstetrics, gynaecology, and anaesthesiology.
Established in: 2019
Managing Director: Dr. Pragnesh Yashwantsinh Bharpoda
Peers:
| Metric | Gujarat Kidney Limited |
Yatharth Hospital & Trauma Care Services Limited |
GPT Healthcare Limited |
KMC Speciality Hospitals (India) Ltd |
|
Current market price (CMP) |
[●] | 822 | 149 | 69 |
| Face Value (₹ per share) | 2 | 10 | 10 | 1 |
| Revenue from Operations (₹ Cr) | 119.97 | 880.49 | 407.09 | 231.60 |
| Earnings Per Share (Basic & Diluted) (₹) | 2.89 | 14.72 | 6.08 | 1.31 |
|
NAV |
7.53 | 166.62 | 30.21 | 10.08 |
|
PAT |
12.61 | 14.83 | 12.26 | 9.225 |
| P/E | [●] | 55.84 | 24.51 | 52.60 |
| Return on Net Worth (RoNW) (%) | 38.38 | 8.13 | 20.14 | 13.04 |
Gujarat Kidney & Super Speciality Objectives
1. The company proposes acquisition of Parekhs Hospital, Ahmedabad for ₹77.00 crore.
2. It plans part-payment for Ashwini Medical Centre acquisition, ₹12.40 crore.
3. Funds will support capital expenditure for a new Vadodara hospital, ₹30.10 crore.
4. The company intends to buy robotics equipment for Vadodara hospital, ₹6.83 crore.
5. Full or part repayment of secured borrowings is planned, ₹1.20 crore.
6. It aims to fund inorganic growth through unidentified acquisitions and general corporate purposes.
7. The company seeks additional shares in Harmony Medicare Private Limited, Bharuch, ₹10.78 crore.
Gujarat Kidney IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹250.80 Cr |
| Offer For Sale | - |
| Fresh Issue | ₹250.80 Cr |
Gujarat Kidney IPO Lot Size
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 128 | 13,824 |
| Retail (Max) | 13 | 1,664 | 1,79,712 |
| S-HNI (Min) | 14 | 1,792 | 1,93,536 |
| S-HNI (MAX) | 68 | 8,704 | 9,92,256 |
| B-HNI (Min) | 69 | 8,832 | 9,53,856 |
Gujarat Kidney IPO Reservation
| Investors Category | Subscription (times) | Shares Offered* | Shares bid for | Total Amount (Cr.)* |
|---|---|---|---|---|
| QIB (Ex Anchor) | 1.06 | 77,26,880 | 81,88,928 | 93.35 |
| Non-Institutional Buyers | 5.72 | 33,00,000 | 1,88,85,504 | 215.29 |
| bNII (bids above ₹10L) | 5.25 | 22,00,000 | 1,15,52,896 | 131.70 |
| sNII (bids below ₹10L) | 6.67 | 11,00,000 | 73,32,608 | 83.59 |
| Individual Investors (IND category bidding for 2 Lots) | 18.91 | 22,00,000 | 4,16,06,784 | 474.32 |
| Total** | 5.19 | 1,32,26,880 | 6,86,81,216 | 782.97 |
*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Revenue | - | 4.77 | 40.24 |
| EBITDA | -0.00 | 1.95 | 16.55 |
| PAT | -0.00 | 1.71 | 9.50 |
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Total Assets | 3.87 | 20.53 | 55.34 |
| Share Capital | 0.20 | 0.20 | 11.37 |
| Total Liabilities | 3.50 | 9.72 | 28.22 |
| Cash Flows (₹ Crores) | FY23 | FY24 | FY25 |
| Net Cash Generated From / (used in) Operating Activities | 0.00 | 1.21 | 13.61 |
| Net Cash Generated From / (used in) Investing Activities | - | 0.22 | -18.14 |
| Net Cash Generated From / (used in) Financing Activities | - | -0.47 | 6.16 |
| Net Increase (Decrease) in Cash and Cash Equivalents | 0.00 | 0.97 | 1.63 |
Strengths
1. Operates seven multispeciality hospitals across Gujarat.
2. Offers both secondary and tertiary care services.
3. Strong presence in Vadodara and key cities.
4. Wide range of super-speciality medical treatments.
Weaknesses
1. Operational bed capacity below total approved beds.
2. Limited presence outside Gujarat reduces market reach.
3. High dependence on hospital revenue streams.
4. Capital-intensive expansions may strain finances.
Opportunities
1. Proposed acquisition of Parekhs Hospital, Ahmedabad.
2. Expansion into robotics and advanced medical equipment.
3. Potential for inorganic growth through acquisitions.
4. Rising healthcare demand in Gujarat region.
Threats
1. Competition from other multispeciality hospitals nearby.
2. Regulatory changes could impact hospital operations.
3. Economic downturn may reduce patient affordability.
4. Dependence on skilled professionals for specialised services.
1. Strong presence across multiple cities in Gujarat.
2. Expanding super-speciality services and advanced treatment facilities.
3. Strategic acquisitions enhance growth and market reach.
4. Robust potential from rising regional healthcare demand.
Gujarat Kidney and Super Speciality Limited operates in a rapidly growing healthcare market in Gujarat. With seven hospitals and four pharmacies, it addresses increasing demand for secondary and tertiary care. Expanding services in super-specialities, robotics, and new hospital setups enhance its growth prospects. Strategic acquisitions and modern infrastructure position the company to capture a larger patient base, strengthen regional presence, and benefit from rising healthcare awareness and spending.
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Gujarat Kidney IPO opens from December 22, 2025 to December 24, 2025.
The size of Gujarat Kidney IPO is ₹250.80.
The price band of Gujarat Kidney IPO is fixed at ₹108 to ₹114.
To apply for Gujarat Kidney IPO, follow the steps given below:
● Login to your 5paisa demat account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Gujarat Kidney. IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size of Gujarat Kidney IPO is of 128 shares and the investment required is ₹13,824.
The share allotment date of Gujarat Kidney IPO is December 26, 2025
The Gujarat Kidney IPO will likely be listed on December 30, 2025.
Nirbhay Capital Services Pvt.Ltd is the book running lead managers for Gujarat Kidney IPO.
Gujarat Kidney IPO plans to utilise the raised capital from the IPO for:
1. The company proposes acquisition of Parekhs Hospital, Ahmedabad for ₹77.00 crore.
2. It plans part-payment for Ashwini Medical Centre acquisition, ₹12.40 crore.
3. Funds will support capital expenditure for a new Vadodara hospital, ₹30.10 crore.
4. The company intends to buy robotics equipment for Vadodara hospital, ₹6.83 crore.
5. Full or part repayment of secured borrowings is planned, ₹1.20 crore.
6. It aims to fund inorganic growth through unidentified acquisitions and general corporate purposes.
7. The company seeks additional shares in Harmony Medicare Private Limited, Bharuch, ₹10.78 crore.